• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肌萎缩侧索硬化症中,嗜铬粒蛋白A和磷酸化神经丝重链的脑脊液水平升高。

Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.

作者信息

Kaiserova M, Grambalova Z, Otruba P, Stejskal D, Prikrylova Vranova H, Mares J, Mensikova K, Kanovsky P

机构信息

Department of Neurology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic.

AGEL Research and Training Institute, Prostejov, Czech Republic.

出版信息

Acta Neurol Scand. 2017 Oct;136(4):360-364. doi: 10.1111/ane.12735. Epub 2017 Feb 10.

DOI:10.1111/ane.12735
PMID:28185258
Abstract

BACKGROUND

Various cerebrospinal fluid (CSF) biomarkers are being studied to improve the sensitivity and specificity of the diagnostic methods for amyotrophic lateral sclerosis (ALS).

AIMS OF THE STUDY

The aim of our study was to establish the CSF levels of chromogranin A (CgA) and phosphorylated neurofilament heavy chain (pNF-H) in patients with ALS in order to assess these proteins as possible biomarkers of ALS.

METHODS

Cerebrospinal fluid levels of CgA and pNF-H were examined and mutually compared in 15 patients with sporadic ALS and 16 gender- and age-matched controls.

RESULTS

Lumbar CSF CgA levels were increased in the patients with ALS compared to the controls (median 235 vs 138, P=.031). Lumbar CSF pNF-H levels were significantly increased in the patients with ALS compared to the control group (median 3091 vs 213, P<.0001).

CONCLUSIONS

Identifying CSF biomarkers in ALS is important in order to establish the diagnosis in the early stages of the disease. pNF-H seems to be a good biomarker for the diagnosis of ALS. If confirmed on a larger group of patients, CgA may also become useful in the diagnosis of sporadic ALS.

摘要

背景

正在研究多种脑脊液(CSF)生物标志物,以提高肌萎缩侧索硬化症(ALS)诊断方法的敏感性和特异性。

研究目的

我们研究的目的是确定ALS患者脑脊液中嗜铬粒蛋白A(CgA)和磷酸化神经丝重链(pNF-H)的水平,以便评估这些蛋白质作为ALS可能的生物标志物。

方法

检测并相互比较了15例散发性ALS患者和16例年龄及性别匹配的对照者脑脊液中CgA和pNF-H的水平。

结果

与对照组相比,ALS患者腰椎脑脊液中CgA水平升高(中位数235对138,P = 0.031)。与对照组相比,ALS患者腰椎脑脊液中pNF-H水平显著升高(中位数3091对213,P < 0.0001)。

结论

在ALS中识别脑脊液生物标志物对于在疾病早期阶段确立诊断很重要。pNF-H似乎是诊断ALS的良好生物标志物。如果在更大规模的患者群体中得到证实,CgA在散发性ALS的诊断中也可能会变得有用。

相似文献

1
Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.在肌萎缩侧索硬化症中,嗜铬粒蛋白A和磷酸化神经丝重链的脑脊液水平升高。
Acta Neurol Scand. 2017 Oct;136(4):360-364. doi: 10.1111/ane.12735. Epub 2017 Feb 10.
2
Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中嗜铬粒蛋白 A 水平。
Neurobiol Aging. 2018 Jul;67:21-22. doi: 10.1016/j.neurobiolaging.2018.02.017. Epub 2018 Feb 27.
3
CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.脑脊液神经丝蛋白作为肌萎缩侧索硬化症的诊断和预后生物标志物。
J Neurol. 2018 Mar;265(3):510-521. doi: 10.1007/s00415-017-8730-6. Epub 2018 Jan 10.
4
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.外周血和脑脊液中磷酸化神经丝重链 (pNF-H) 作为肌萎缩侧索硬化症的潜在预后生物标志物。
J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):467-72. doi: 10.1136/jnnp-2012-303768. Epub 2012 Oct 31.
5
Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者配对血浆和脑脊液中磷酸化神经丝重链水平
J Neurol Sci. 2016 Aug 15;367:269-74. doi: 10.1016/j.jns.2016.05.062. Epub 2016 Jun 1.
6
Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.神经丝水平作为无症状和有症状家族性肌萎缩侧索硬化症的生物标志物。
Ann Neurol. 2016 Jan;79(1):152-8. doi: 10.1002/ana.24552. Epub 2015 Dec 17.
7
Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.用于诊断肌萎缩侧索硬化症的多种生物标志物组合的评估
BMC Neurol. 2016 Sep 15;16:173. doi: 10.1186/s12883-016-0689-x.
8
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype.肌萎缩侧索硬化症患者脑脊液中神经丝轻链水平:超氧化物歧化酶1基因型的影响
Eur J Neurol. 2007 Dec;14(12):1329-33. doi: 10.1111/j.1468-1331.2007.01972.x. Epub 2007 Sep 26.
9
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.CSF 生物标志物在肌萎缩侧索硬化症中的神经退行性变和神经炎症的诊断预后价值及电生理学相关性。
J Neurol. 2020 Jun;267(6):1699-1708. doi: 10.1007/s00415-020-09761-z. Epub 2020 Feb 25.
10
Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.脑脊液神经丝在运动神经元病患者队列中的诊断和预后价值:一项横断面研究。
J Cell Mol Med. 2021 Apr;25(8):3765-3771. doi: 10.1111/jcmm.16240. Epub 2021 Feb 20.

引用本文的文献

1
Biomarkers in Ataxia-Telangiectasia: a Systematic Review.共济失调毛细血管扩张症中的生物标志物:一项系统综述
J Neurol. 2025 Jan 15;272(2):110. doi: 10.1007/s00415-024-12766-7.
2
Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis.利用神经退行性标志物对肌萎缩性侧索硬化症进行诊断评估。
Eur J Med Res. 2024 Jan 6;29(1):31. doi: 10.1186/s40001-023-01596-4.
3
Filtered Cerebrospinal Fluid From Patients With Amyotrophic Lateral Sclerosis Displays an Altered Proteome and Affects Motor Phenotype in a Mouse Model.
来自肌萎缩侧索硬化症患者的过滤脑脊液显示蛋白质组改变并影响小鼠模型的运动表型。
Cureus. 2022 Dec 26;14(12):e32980. doi: 10.7759/cureus.32980. eCollection 2022 Dec.
4
Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status.神经退行性疾病的生物标志物:生物学、分类学、临床相关性及当前研究现状
Biomedicines. 2022 Jul 21;10(7):1760. doi: 10.3390/biomedicines10071760.
5
Cerebrospinal Fluid Levels of Chromogranin A in Parkinson's Disease and Multiple System Atrophy.帕金森病和多系统萎缩患者脑脊液中嗜铬粒蛋白A的水平
Brain Sci. 2021 Jan 22;11(2):141. doi: 10.3390/brainsci11020141.
6
BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers.BAMBI 和 CHGA 在朊病毒病中的作用:神经病理学评估和作为疾病生物标志物的潜在作用。
Biomolecules. 2020 May 2;10(5):706. doi: 10.3390/biom10050706.
7
SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease.采用数据独立采集质谱分析法对脑脊液进行分析,以生成一套用于阿尔茨海默病的强大生物标志物组合。
Sci Rep. 2020 May 4;10(1):7423. doi: 10.1038/s41598-020-64461-y.
8
Significance of CSF NfL and tau in ALS.CSF NfL 和 tau 在 ALS 中的意义。
J Neurol. 2018 Nov;265(11):2633-2645. doi: 10.1007/s00415-018-9043-0. Epub 2018 Sep 5.
9
Salivary biomarkers for the diagnosis and monitoring of neurological diseases.唾液生物标志物用于神经疾病的诊断和监测。
Biomed J. 2018 Apr;41(2):63-87. doi: 10.1016/j.bj.2018.03.004. Epub 2018 May 10.